NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
InformedHealth. org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Preventing Gestational Diabetes
Last Update: April 17, 2024 ; Next update: 2027.
Engaging in enough physical activity and adjusting dietary habits can help some women avoid developing gestational diabetes during pregnancy. However, it remains uncertain whether this also reduces the chances of pregnancy and childbirth complications.
Pregnancy causes changes in women’s metabolism, leading to temporary spikes in blood sugar levels. If these levels surpass certain thresholds, gestational diabetes is diagnosed. Factors like obesity, family history of diabetes, and previous gestational diabetes increase the risk of developing the condition.
Dietary Recommendations for Gestational Diabetes Prevention
Pregnant women are typically encouraged to follow a well-rounded diet. For most women, listening to their appetite and sticking to a regular diet suffices. Adjusting dietary habits can help lower blood sugar levels and manage weight gain throughout pregnancy.
Studies indicate beneficial effects of dietary modifications for overweight or obese women, yet the impact on pregnancy complications remains inconclusive.
Research hasn’t determined whether dietary changes affect a child’s birth weight or the need for Cesarean sections.
Balanced Diet and Weight Management in Gestational Diabetes Prevention
Reducing carbohydrate intake, maintaining fiber levels, and following a balanced diet can help control blood sugar levels in pregnancy. Dietary adjustments should be tailored to weight and activity levels, with input from a dietitian to ensure proper nutrition and avoid adverse effects.
Sufficient calorie and nutrient intake during pregnancy are vital, and cutting calories isn’t recommended.
Risk of Excessive Weight Gain in Pregnancy
Excessive weight gain during pregnancy heightens health risks and complications during childbirth. Official guidelines advise on appropriate weight gain levels based on pre-pregnancy weight.
Impact of Dietary Supplements on Gestational Diabetes
Supplements containing myo-inositol may lower the risk of gestational diabetes by enhancing insulin efficacy. Women taking myo-inositol experience fewer blood pressure-related conditions like pre-eclampsia. The link between vitamin D deficiency and gestational diabetes risk is uncertain, as supplement preventive effects require further investigation.
Omega-3 fatty acids and probiotics haven’t shown preventative benefits for gestational diabetes, with probiotics potentially increasing the risk of blood pressure-related conditions.
Role of Exercise in Preventing Gestational Diabetes
Regular exercise reduces the likelihood of gestational diabetes in women, regardless of their weight. Combining dietary modifications with exercise regimes can aid in preventing gestational diabetes.
Although exercise doesn’t elevate the risk of premature birth, its impact on childbirth complications and Cesarean sections isn’t clearly understood.
Recommended Physical Activity for Gestational Diabetes Prevention
Partaking in at least 30 minutes of vigorous exercise on 3-4 days per week can lower blood sugar levels. Suitable activities include swimming, cycling, and brisk walking, while avoiding high-risk sports is advised. Consulting a doctor before starting an exercise regimen is recommended.
Effectiveness of Metformin in Gestational Diabetes Prevention
Metformin, a blood sugar-lowering medication, doesn’t prevent gestational diabetes or related childbirth complications. Possible side effects like diarrhea are associated with metformin use, and it isn’t officially endorsed for gestational diabetes prevention.
German Guidelines on Gestational Diabetes
German guidelines offer insights into gestational diabetes diagnosis, treatment, and follow-up. Quality health information aims to educate individuals on treatment options and healthcare services.
Healthcare providers should be consulted on individual cases due to potential variations in health information based on regional healthcare systems.
If diagnosed with gestational diabetes, questions may arise regarding the condition, treatment, beneficial supplements, and preventive strategies. Gestational diabetes (GD), a form of diabetes that emerges during pregnancy, impacts about 10% of pregnancies in the US, making it a prevalent complication.
Signs and Symptoms of Gestational Diabetes
Gestational diabetes involves elevated blood sugar levels during pregnancy, typically resolving following delivery.
Untreated gestational diabetes can lead to severe health issues for both the mother and baby. Pregnancy complications such as pre-eclampsia, preterm labor, neonatal hypoglycemia, and cesarean delivery are associated with gestational diabetes. Additionally, it heightens the risk of future conditions like hypertension, type 2 diabetes, fatty liver disease, and cardiovascular disease for both mother and child.
Risk Factors for Gestational Diabetes
Risk factors for developing gestational diabetes include obesity, previous gestational diabetes history, family history of type 2 diabetes, prior birth of a large baby, age over 40, prediabetes, certain ethnicities, and polycystic ovary syndrome (PCOS).
Prevention and Management of Gestational Diabetes
Maintaining a healthy weight through diet and exercise is crucial in preventing gestational diabetes. A diet rich in vegetables, fruits, whole grains, nuts, legumes, and fish can lower the risk, while limiting red meat, processed meat, and eggs is advised. Focusing on health before and during pregnancy is essential for reducing the likelihood of gestational diabetes, and avoiding rapid weight gain during pregnancy is key.
Nutritional Supplements for Gestational Diabetes Prevention
Studies suggest that nutritional supplements can aid in preventing gestational diabetes, with potential benefits from supplements like vitamin D, inositol, magnesium, and fish oil. While conflicting results exist in smaller studies, larger trials are needed to definitively establish the effectiveness of these supplements.
Treatment of Gestational Diabetes
While diet and exercise can help manage blood sugar levels in gestational diabetes, some women may require insulin therapy. Insulin is considered safe and effective, with ongoing research on the safety and efficacy of other diabetes medications during pregnancy. Healthcare providers should be consulted to determine the most suitable treatment plan.
Monitoring Gestational Diabetes
Monitoring blood glucose levels at home is crucial to evaluate the management of gestational diabetes. Regular testing and adherence to recommended blood glucose level targets are essential for optimal management, with guidance from healthcare providers on monitoring practices.
Importance of Screening for Gestational Diabetes
Regular screening through healthcare providers is critical, especially for individuals at higher risk of developing gestational diabetes. Maintaining a healthy lifestyle and considering nutritional supplements can aid in preventing gestational diabetes and promoting a healthy pregnancy.
Received 2022 Feb 3; Accepted 2022 Mar 18; Collection date 2022.
This work is licensed under a Creative Commons Attribution License (CC BY). Proper credit to the original author(s) and publication is necessary in any distribution or reproduction of this work.
Impact of Nutritional Supplementation on Gestational Diabetes Risk
Nutritional status before and during pregnancy significantly influences women’s health and fetal development. Hormonal changes during pregnancy affect insulin resistance and nutrient utilization by the fetus. Gestational Diabetes Mellitus (GDM) is a prevalent pregnancy complication with severe consequences. Research indicates that physical activity, healthy eating, and supplements can lower the risk of GDM. Supplements like Myo-Inositol, maternal vitamin D, and probiotics show promise in controlling glucose levels. This review explores the role of nutritional supplements in GDM risk reduction and glycemic control. Keywords: pregnancy, gestational diabetes, Myo-Inositol, probiotics, vitamin D, omega-3.
Prioritizing nutrition before and during pregnancy is crucial for positive outcomes and long-term health. GDM is linked to pregnancy and metabolic issues. Dietary choices can impact GDM risk – the consumption of vegetables, fruits, nuts can lower the risk, while excessive red and processed meats may increase it. Guidance on dietary practices is vital for managing GDM. Maternal obesity is a significant risk factor for GDM, affecting insulin resistance and micronutrient deficiencies. Although nutritional interventions aim to reduce GDM risk, challenges like adherence persist. Supplements such as probiotics, Myo-Inositol, and vitamin D hold potential in preventing GDM. Nonetheless, research on supplement effectiveness in GDM prevention requires further exploration. This review discusses evidence on common supplement use and future directions in GDM prevention and treatment.
A summary of systematic reviews and meta-analyses on the effects of nutritional supplementation during pregnancy can be found in Table 1.
Probiotic Supplementation
Microorganisms are inhabitants of various human tissues and bodily fluids, including the skin, mouth, saliva, nose, vagina, seminal fluid, and mammary glands. The majority of these microorganisms reside in the gut due to nutrient availability. The human gut microbiota is composed of around 100 trillion microorganisms belonging to 5,000 species, playing essential roles in digestion, immunity, neurological signaling, endocrine function, drug metabolism, and the production of secondary compounds affecting the host’s physiology.
The dominant phyla in the gut microbiota of healthy adults are Bacteroidetes and Firmicutes. These phyla are responsible for producing short-chain fatty acids (SCFAs) through the fermentation of dietary fiber, which can influence various bodily functions such as insulin sensitivity, appetite, and inflammation. Imbalance in the gut microbiota, known as dysbiosis, has been associated with metabolic disorders like obesity and diabetes, including gestational diabetes mellitus (GDM).
Probiotics, which are live microorganisms that provide health benefits, have been demonstrated to restore gut microbial balance, enhance barrier function, reduce inflammation, and regulate insulin production. The supplementation of probiotics during pregnancy can alter the composition of gut microbiota, leading to improvements in glucose and lipid metabolism. However, studies have yielded conflicting results regarding the prevention of GDM in overweight and obese women, emphasizing the importance of species-specific clinical benefits.
In conclusion, addressing dysbiosis in the gut microbiota through probiotics and other interventions may have the potential to enhance outcomes for women with GDM. Further exploration of personalized supplementation and long-term effects is crucial to advance the understanding of microbiota-targeted therapies.
Fish Oils and Fatty Acids Supplementation
Fish are rich in long-chain polyunsaturated fatty acids. The connection between fish consumption and metabolic disorders is a topic of debate, with certain types of fish reducing the risk of type 2 diabetes mellitus (T2DM) while others may increase it. Gender and geographical location play a role in this relationship. During pregnancy, it is essential to consider the presence of mercury in fish, although there are no universal guidelines. Plant-based sources also offer Omega-3 polyunsaturated fatty acids (O-3-PUFA) like EPA and DHA, which possess anti-inflammatory properties and provide various benefits, including enhanced insulin sensitivity and crucial support for fetal organ development.
O-3-PUFA contribute to normalizing lipid profiles during pregnancy, even in cases of GDM. GDM exacerbates disturbances in lipid metabolism, with high triglyceride levels correlating with neonatal weight and associated risks. Omega-3 supplementation has shown efficacy in reducing triglyceride levels, and purified EPA forms also have benefits in reducing cardiovascular risks.
The evidence on Omega-3 supplementation during pregnancy remains inconclusive, necessitating further research to determine the advantages for pregnant women, particularly those with GDM. Future studies should commence early in pregnancy, be adequately powered, and consider a dosage of 4 grams of Omega-3.
Vitamin D Supplementation
Vitamin D deficiency is prevalent during pregnancy and is linked to complications such as GDM and preeclampsia. Different regions have varying definitions of Vitamin D deficiency, and research findings on the association between Vitamin D deficiency and the risk of GDM have been conflicting. Supplementation has demonstrated improvements in glucose metabolism among women with GDM, and investigations are ongoing to explore the combined effects of Vitamin D with other supplements in enhancing various markers and reducing complications.
Assessing Vitamin D levels early in pregnancy may guide personalized interventions beneficial to pregnant women. Further research is warranted to elucidate the optimal utilization of Vitamin D in the prevention and management of GDM.
MYO-Inositol Supplementation
Myo-Inositol, a compound present in various foods, plays a significant role in insulin sensitivity and glucose metabolism by restoring glucose uptake and insulin sensitivity. Research has indicated that Myo-Inositol can reduce the incidence of GDM in pregnant women, and additional studies support its potential benefits in lowering the risk of GDM and improving outcomes.
The potential of Myo-Inositol to enhance insulin sensitivity suggests that it might aid in preventing GDM in overweight women, women with obesity, those with PCOS, or individuals with a family history of type 2 diabetes. Large-scale randomized controlled trials involving diverse ethnic groups and comprehensive risk factor analyses are necessary before recommending Myo-Inositol for GDM prevention.
Other Supplements
Magnesium supplementation has been shown to enhance glucose metabolism in individuals with diabetes and improve insulin sensitivity in those at high risk of diabetes. Moreover, a 6-week magnesium supplementation regimen in women with gestational diabetes mellitus (GDM) has demonstrated positive effects on the expression of inflammatory markers and genes related to insulin and lipid metabolism. This could potentially lead to a reduction in metabolic complications in women with GDM. A recent meta-analysis indicated that omega-3 fatty acids, magnesium, Vitamin D, zinc, and probiotics were more effective in improving fasting blood glucose, serum insulin, and HOMA-IR levels compared to a placebo. Notably, magnesium supplementation was particularly effective in reducing serum insulin levels.
Zinc and selenium are essential trace elements necessary for the activity of glutathione peroxidase and other antioxidant functions. Research has shown that serum selenium levels are significantly lower in women with GDM, while the zinc status does not differ between women with and without GDM. However, there is limited evidence to support the idea that zinc supplementation during pregnancy can enhance outcomes.
There is no concrete evidence linking iron supplementation to the risk of GDM. Interestingly, pregnant women with iron deficiency anemia are less likely to develop GDM. High levels of iron biomarkers have been associated with GDM, but overall there is inconclusive evidence linking routine iron supplementation in non-anemic women to an increased risk of GDM.
To better understand the interplay between these minerals and the risk of GDM, well-designed prospective studies are necessary.
The use of vitamin D, Myo-Inositol, probiotics, and omega-3 fatty acids during pregnancy has been linked to reduced systemic inflammation and improved insulin resistance and signaling. Recent meta-analyses have highlighted the effectiveness of these supplements in enhancing glucose markers, with vitamin D supplementation significantly reducing fasting plasma glucose levels and regulating HOMA-IR levels. Magnesium supplementation was particularly effective in lowering serum insulin levels.
A recent trial explored the impact of Myo-Inositol, probiotics, and multiple micronutrients on gestational normoglycemia and preterm birth, showing a decrease in major postpartum hemorrhage incidence and a potential benefit in reducing preterm birth rates. Further studies are required to elucidate these effects across different populations and risk factors.
A Cochrane review has indicated unknown benefits or risks associated with various interventions on GDM risk, with promising evidence for Myo-Inositol and vitamin D supplementation in lowering the risk of GDM.
GDM serves as a crucial marker for the development of Type 2 diabetes in the future. Antenatal supplementation with Myo-Inositol, vitamin D, and probiotics may offer a viable intervention. However, additional studies are needed to evaluate their effects on maternal and neonatal outcomes. A trial is currently in progress to evaluate the impact of antenatal Myo-Inositol supplementation on GDM and fetal outcomes.
Before drawing definitive conclusions, it is essential to take into account various subgroup populations, supplement dosage regimens, and the optimal timing for initiating supplementation. Monitoring longitudinal changes in supplement levels may help in delineating potential pathways of effect for future trials.
– Simeonova-Krstevska S, Krstevska B, Velkoska-Nakova V, Hadji Lega M, Samardjiski I, Serafimoski V, et al. The impact of lipid parameters on fetal growth in pregnancies affected by gestational diabetes mellitus. The study was published in Pril. (2014) and can be accessed via DOI or PubMed.
– Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as prognostic factors for having large-for-gestational age newborns in women with gestational diabetes mellitus. The findings were published in Acta Obstet Gynecol Scand in 2010.
– Jamilian M, Samimi M, Ebrahimi FA, Hashemi T, Taghizadeh M, Razavi M, et al. Research on the effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid levels in gestational diabetes patients. The study was published in J Clin Lipidol in 2017.
– Contreras-Duarte S, Carvajal L, Garchitorena MJ, Subiabre M, Fuenzalida B, Cantin C, et al. Treatment regimens for gestational diabetes mellitus affect maternal plasma cholesterol levels based on the weight of women, potentially influencing feto-placental vascular function. This study was published in Nutrients in 2020.
– Bhatt DL, Ste..
– Bizzarri M, Carlomagno G. The historical overview of successful therapy for PCOS published in Eur Rev Med Pharmacol Sci. (2014).
– Croze ML, Soulage CO. The potential impact of myo-inositol on metabolic diseases examined in Biochimie. (2013).
– Cabrera-Cruz H, Oróstica L, Plaza-Parrochia F, Torres-Pinto I, Romero C, Vega M. The insulin-sensitizing mechanism of myo-inositol, AMPK activation and GLUT-4 expression in endometrial cells were explored. The study was published in Am J Physiol Endocrinol Metab in 2020.
– Farren M, Daly N, McKeating A, Kinsley B, Turner MJ, Daly S. A randomized controlled trial on antenatal oral inositol supplementation as a means for preventing gestational diabetes. The study was published in Diabetes Care in 2017.
– D’anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Lieta Interdonato M, et al. A prospective, randomized, placebo-controlled study on myo-inositol supplementation and the onset of gestational diabetes in pregnant women with a family history of type 2 diabetes. The research was published in Diabetes Care in 2013.